C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor

Immunity

Volumn 18, Issue 6, 2003, Pages 837-848

  Brodeur, Scott R ^a   Angelini, Federica ^a,e   Bacharier, Leonard B ^a,f   Blom, Anna M ^b   Mizoguchi, Emiko ^c   Fujiwara, Hiroshi ^a,g   Plebani, Alessandro ^d   Notarangelo, Luigi D ^d   Dahlback, Bjorn ^b   Tsitsikov, Erdyni ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b LUND UNIVERSITY   (Sweden)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f WASHINGTON UNIVERSITY   (United States)

^g OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD40 LIGAND; CD86 ANTIGEN; COMPLEMENT COMPONENT C4B BINDING PROTEIN; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; PROTEIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TONSIL; UPREGULATION;

EID: 0038503986     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00149-3     Document Type: Article

References (67)

1. Aicher A., Shu G.L., Magaletti D., Mulvania T., Pezzutto A., Craxton A., Clark E.A. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 163:1999;5786-5795.
2. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922. a.
3. Banchereau J., Briere F., Liu Y.J., Rousset F. Molecular control of B lymphocyte growth and differentiation. Stem Cells. 12:1994;278-288. b.
4. Berberich I., Shu G.L., Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153:1994;4357-4366.
5. Berggard K., Johnsson E., Mooi F.R., Lindahl G. Bordetella pertussis binds the human complement regulator C4BP. role of filamentous hemagglutinin Infect. Immun. 65:1997;3638-3643.
6. Blom A.M., Webb J., Villoutreix B.O., Dahlback B. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274:1999;19237-19245.
7. Blom A.M., Kask L., Dahlback B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276:2001;27136-27144. a.
8. Blom A.M., Rytkonen A., Vasquez P., Lindahl G., Dahlback B., Jonsson A.B. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein. J. Immunol. 166:2001;6764-6770. b.
9. Blom A.M., Kask L., Dahlback B. CCP1-4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of C3b. Mol. Immunol. 39:2003;547-556.
10. Brady K., Fitzgerald S., Ingvarsson S., Borrebaeck C.A., Moynagh P.N. CD40 employs p38 MAP kinase in IgE isotype switching. Biochem. Biophys. Res. Commun. 289:2001;276-281.
11. Calderhead D.M., Kosaka Y., Manning E.M., Noelle R.J. CD40-CD154 interactions in B-cell signaling. Curr. Top. Microbiol. Immunol. 245:2000;73-99.
12. Castigli E., Alt F.W., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., Geha R.S. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91:1994;12135-12139.
13. Challa A., Pound J.D., Armitage R.J., Gordon J. Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis in human B cells. Allergy. 54:1999;576-583.
14. Chu Y.W., Marin E., Fuleihan R., Ramesh N., Rosen F.S., Geha R.S., Insel R.A. Somatic mutation of human immunoglobulin V genes in the X-linked HyperIgM syndrome. J. Clin. Invest. 95:1995;1389-1393.
15. Cleary A.M., Fortune S.M., Yellin M.J., Chess L., Lederman S. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J. Immunol. 155:1995;3329-3337.
16. Cooper S.T., Attie A.D. Pig apolipoprotein R. a new member of the short consensus repeat family of proteins Biochemistry. 31:1992;12328-12336.
17. Criado Garcia O., Sanchez-Corral P., Rodriguez de Cordoba S. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J. Immunol. 155:1995;4037-4043.
18. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
19. Dadgostar H., Zarnegar B., Hoffmann A., Qin X.F., Truong U., Rao G., Baltimore D., Cheng G. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc. Natl. Acad. Sci. USA. 99:2002;1497-1502.
20. Dahlback B., Hildebrand B. Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex. Biochem. J. 209:1983;857-863.
21. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., Bodemer C., Kenwrick S., Depuis-Girod S., Blanche S.et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27:2001;277-285.
22. Ferrari S., Giliani S., Insalaco A., Al-Ghonaium A., Soresina A.R., Loubser M., Avanzini M.A., Marconi M., Bodolato R., Ugazio A.G.et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA. 98:2001;12614-12619.
23. Garcia de Frutos P., Hardig Y., Dahlback B. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270:1995;26950-26955.
24. Gigli I., Fujita T., Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. USA. 76:1979;6596-6600.
25. Golay J., Cusmano G., Introna M. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149:1992;300-308.
26. Grammer A.C., Bergman M.C., Miura Y., Fujita K., Davis L.J., Lipsky P.E. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:1995;4996-5010.
27. Hessing M., Vlooswijk R.A., Hackeng T.M., Kanters D., Bouma B.N. The localization of heparin-binding fragments on human C4b-binding protein. J. Immunol. 144:1990;204-208.
28. Hillarp A., Dahlback B. Novel subunit in C4b-binding protein required for protein S binding. J. Biol. Chem. 263:1988;12759-12764.
29. Hillarp A., Hessing M., Dahlback B. Protein S binding in relation to the subunit composition of human C4b-binding protein. FEBS Lett. 259:1989;53-56.
30. Iciek L.A., Delphin S.A., Stavnezer J. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB. synergy with IL-4 induction J. Immunol. 158:1997;4769-4779.
31. Ishida T., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA. 93:1996;9437-9442.
32. Jabara H.H., Fu S.M., Geha R.S., Vercelli D. CD40 and IgE. Synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells J. Exp. Med. 172:1990;1861-1864.
33. Jabara H.H., Ahern D.J., Vercelli D., Geha R.S. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147:1991;1557-1560.
34. Jabara H.H., Brodeur S.R., Geha R.S. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107:2001;371-378.
35. Jabara H., Laouini D., Tsitsikov E., Mizoguchi E., Bhan A., Castigli E., Dedeoglu F., Piviniouk V., Brodeur S., Geha R. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity. 17:2002;265-276.
36. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2:2001;223-228.
37. Johnsson E., Thern A., Dahlback B., Heden L.O., Wikstrom M., Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J. Immunol. 157:1996;3021-3029.
38. Kask L., Hillarp A., Ramesh B., Dahlback B., Blom A.M. Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry. 41:2002;9349-9357.
39. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice. impaired immunoglobulin class switching and germinal center formation Immunity. 1:1994;167-178.
40. Kusada-Funakoshi M., Sasaki J., Takada Y., Soji T., Arakawa K. Evidence that C4b-binding protein (proline-rich protein) is synthesized by hepatocytes. Biochem. Med. Metab. Biol. 45:1991;350-354.
41. Lappin D.F., Whaley K. Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem. J. 271:1990;767-772.
42. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 96:1999;9136-9141.
43. Liu Y.J., Malisan F., de Bouteiller O., Guret C., Lebecque S., Banchereau J., Mills F.C., Max E.E., Martinez-Valdez H. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity. 4:1996;241-250.
44. Manis J.P., Tian M., Alt F.W. Mechanism and control of class-switch recombination. Trends Immunol. 23:2002;31-39.
45. Mizoguchi E., Mizoguchi A., Bhan A.K. Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice. Lab. Invest. 76:1997;385-397.
46. Moffat G.J., Tack B.F. Regulation of C4b-binding protein gene expression by the acute-phase mediators tumor necrosis factor-α, interleukin-6, and interleukin-1. Biochemistry. 31:1992;12376-12384.
47. Morio T., Hanissian S., Geha R.S. Characterization of a 23-kDa protein associated with CD40. Proc. Natl. Acad. Sci. USA. 92:1995;11633-11636.
48. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:2000;553-563.
49. κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:1996;14661-14664.
50. Oettgen H.C., Geha R.S. IgE in asthma and atopy. cellular and molecular connections J. Clin. Invest. 104:1999;829-835.
51. Ogata R.T., Mathias P., Bradt B.M., Cooper N.R. Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein. J. Immunol. 150:1993;2273-2280.
52. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., Nurko S., Rasmussen W.L., Kohler J.R., Gellis S.E.et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J. Clin. Invest. 109:2002;1501-1509.
53. Pardo-Manuel F., Rey-Campos J., Hillarp A., Dahlback B., Rodriguez de Cordoba S. Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement. Proc. Natl. Acad. Sci. USA. 87:1990;4529-4532.
54. Ramesh N., Fuleihan R., Ramesh V., Lederman S., Yellin M.J., Sharma S., Chess L., Rosen F.S., Geha R.S. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int. Immunol. 5:1993;769-773.
55. Ramesh N., Fuleihan R., Geha R. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Immunol. Rev. 138:1994;87-104.
56. Revy P., Muto T., Levy Y., Geissmann F., Plebani A.et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:2000;565-575.
57. Richards M.L., Katz D.H. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23). comparison with the germline epsilon promoter J. Immunol. 158:1997;263-272.
58. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
59. Sarma V., Lin Z., Clark L., Rust B.M., Tewari M.et al. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:1995;12343-12346.
60. Schwalbe R.A., Dahlback B., Nelsestuen G.L. Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J. Biol. Chem. 265:1990;21749-21757.
61. Sha W.C. Regulation of immune responses by NF-kappa B/Rel transcription factor. J. Exp. Med. 187:1998;143-146.
62. Spertini F., Chatila T., Geha R.S. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J. Immunol. 149:1992;65-70.
63. Sutherland C.L., Heath A.W., Pelech S.L., Young P.R., Gold M.R. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157:1996;3381-3390.
64. Vyth-Dreese F.A., Dellemijn T.A., Majoor D., de Jong D. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur. J. Immunol. 25:1995;3023-3029.
65. Weckert H.A., Hughes J.A., Benson E.M., Dunn I.S. Quantifiable analysis of human immunoglobulin heavy chain class-switch recombination to all isotypes. J. Immunol. Methods. 233:2000;141-158.
66. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J.J., Waldschmidt T.J., Elsemore J., Noelle R.J., Flavell R.A. Mice deficient for the CD40 ligand. Immunity. 1:1994;423-431.
67. Zhang K., Zhang L., Zhu D., Bae D., Nel A., Saxon A. CD40-mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE. J. Allergy Clin. Immunol. 110:2002;421-428.